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■ Abstract
Background: Component-resolved diagnosis using microarray technology has recently been introduced in clinical allergology, but its 
applicability in patients with natural rubber latex (NRL) allergy has not been investigated. 
Objectives: To evaluate the utility of microarray-based immunoglobulin (Ig) E detection in the diagnostic workup of NRL allergy and to 
compare this new diagnostic tool with established methods of NRL-specifi c IgE detection.
Methods: We investigated 52 adults with immediate-type NRL allergy and 50 control patients. Determination of specifi c serum IgE against 8 
recombinant Hevea brasiliensis allergen components was performed using a customized allergen microarray and a conventional fl uorescence 
enzyme immunoassay (FEIA). 
Results: The panel of microarrayed allergen components was shown to represent a comprehensive repertoire of clinically relevant NRL 
proteins. NRL-specifi c IgE recognition patterns and sensitization rates determined by microarray analysis were similar to those obtained by 
conventional FEIA. The diagnostic sensitivity rates of combined single-component data were not signifi cantly different for the respective 
recombinant test system, whereas the sensitivity level of extract-based FEIA analysis was markedly higher.
Conclusion: The current study provides evidence that microarrays of recombinant NRL allergen components are a suitable new tool for the 
diagnosis of NRL-specifi c sensitization. They show performance characteristics comparable to those of current diagnostic tests and could be 
indicated in small children in whom only limited blood volumes are obtainable. Further large-scale studies in unselected patient populations 
and in high-risk groups are warranted before the microarray can be introduced into routine management of patients with NRL allergy.
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■ Resumen
Antecedentes: El diagnóstico por componentes mediante la tecnología de microarrays ha sido introducido recientemente en la alergología 
clínica, si bien su aplicación en pacientes con alergia al látex de caucho natural no ha sido investigada. 
Objetivos: Evaluar la utilidad de la detección de la inmunoglobulina (lg) E basada en microarrays en el diagnóstico de la alergia al látex 
de caucho natural, y comparar esta nueva herramienta diagnóstica con los métodos establecidos para la detección de IgE específi ca al 
látex de caucho natural.
Métodos: Se estudiaron a 52 adultos con alergia inmediata al látex de caucho natural y 50 pacientes control. Se determinó la IgE 
sérica específi ca frente a 8 componentes alergénicos de Hevea brasiliensis mediante microarrays de alérgenos personalizada y un 
fl uoroenzimoinmunoanálisis (FEIA) convencional. 
Resultados: El panel de componentes alergénicos demostró representar un amplio repertorio de proteínas clínicamente relevantes de látex 
de caucho natural. Los patrones de reconocimiento de lgE específi ca al látex de caucho natural y los índices de sensibilización determinados 
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Introduction
Despite considerable prevention efforts, natural rubber latex 
(NRL) allergy remains an important medical issue, affecting 
nearly 1.5% of the general population, more than 4% of health 
care workers, and up to one-third of patients undergoing multiple 
surgical procedures [1-3]. 
As a natural product of the tropical Hevea brasiliensis tree, 
NRL is an aqueous elastomer emulsion containing mainly 
cis-1,4-polyisoprene (30%-40%) and water (55%-65%), but 
also more than 240 polypeptides. Of these, 13 proteins have 
been identifi ed, characterized, and offi cially accepted as allergen 
components by the International Union of Immunological 
Societies. Most of these allergenic proteins, designated as 
Hev b 1-13, have been recombinantly synthesized and used for 
component-resolved in vitro diagnosis of NRL sensitization by 
our group and other investigators [4-7].
Furthermore, protein microarrays have recently been 
introduced into allergological research as promising tools for 
the simultaneous assessment of specifi c immunoglobulin 
(Ig) E antibodies (sIgE) against multiple recombinant or purifi ed 
natural allergen components [8-10]. We previously demonstrated 
in a proof-of-principle study with NRL-sensitized BALB/c mice 
that detection of sIgE against NRL proteins is feasible using a 
customized allergen microarray [11].
The clinical implications of component-resolved diagnosis 
(CRD) including microarrayed NRL allergens have not been 
investigated. Thus, our main objective was to assess the 
performance of an allergen microarray containing recombinant 
NRL allergen components for sIgE detection in adults with 
latex allergy. We also compared clinically relevant performance 
parameters of this allergen microarray with those of an 
established extract-based and component-based fl uorescence 
enzyme immunoassay (FEIA).
Patients and Methods
Study Population
We analyzed serum samples from 52 adult patients who had 
been referred to our dermatology and allergology outpatient 
departments for evaluation of NRL hypersensitivity. All patients 
had a conclusive history of IgE-mediated allergy occurring 
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mediante el análisis de microarrays fueron similares a los obtenidos con el FEIA convencional. Los índices de sensibilidad diagnósticos de los 
datos combinados de un único componente no fueron signifi cativamente diferentes para el sistema analítico recombinante correspondiente, 
mientras que el nivel de sensibilidad del FEIA basado en extractos fue notablemente superior.
Conclusión: El estudio actual aporta datos que muestran que los microarrays de componentes alergénicos recombinantes de látex de 
caucho natural constituyen una herramienta nueva adecuada para diagnosticar la sensibilización específi ca al látex de caucho natural. 
Esta herramienta presenta características de rendimiento comparables a las de las pruebas diagnósticas actuales, y podría estar indicada 
para su uso en niños pequeños de los que solo se pueden obtener volúmenes de sangre reducidos. Es necesario realizar más estudios a 
gran escala en poblaciones de pacientes no seleccionadas y en grupos de alto riesgo antes de poder introducir las micromatrices en el 
control rutinario de los pacientes con alergia al látex de caucho natural.
Palabras clave: Alergia a látex. Hevea brasiliensis. Microarray. Diagnóstico por componentes.
immediately after NRL exposure and at least 1 positive reaction 
in skin prick tests performed with NRL allergen extracts. The 
severity of the clinical reactions was classifi ed according to 
von Krogh and Maibach [12] as follows: contact urticaria 
(grade 1), generalized urticaria with or without angioedema 
(grade 2), bronchial asthma with or without rhinoconjunctivitis 
(grade 3), and anaphylactic shock (grade 4). Serum samples of 
50 age-matched and sex-matched insect venom–allergic adults 
with no history of latex allergy served as negative controls.
Data processing was performed in accordance with ethical 
standards on human experimentation and with the Declaration 
of Helsinki (1975), as revised in 1983. The study was approved 
by the local ethics committee of the Medical Faculty of the 
RWTH Aachen. 
Protein Microarray Test Procedure
We used a commercially available allergen microarray 
platform (ISAC, VBC Genomics Bioscience Research, Vienna, 
Austria) that has been shown to yield reliable analytical results 
when compared to fl uorescence enzyme immunoassays in other 
clinical settings and with different sets of implemented inhalant 
or food allergen components [8-10]. 
This ambient analyte assay consists of a microscopy glass 
slide modifi ed with a Tefl on mask in order to create 4 individual 
reaction sites. These were coated with amine-reactive polymers 
allowing covalent immobilization of allergenic molecules. In the 
present study, we used a customized version of the microarray 
containing recombinant birch pollen profi lin (rBet v 2) and 
a series of 8 recombinant NRL allergen components–rubber 
elongation factor (rHev b 1), small rubber particle protein 
(rHev b 3), acidic protein (rHev b 5), hevein (rHev b 6.02), 
profi lin (rHev b 8), enolase (rHev b 9), Mn-superoxide dismutase 
(rHev b 10), and class I chitinase (rHev b 11) (Biomay, Vienna, 
Austria)–that were spotted onto the microarray in vertical 
triplicates. As indicated by the manufacturer, the degree of 
purity of the respective allergenic proteins was as follows: 
≥90% (rHev b 1), ≥97% (rHev b 6.02), >98% (rHev b 3, rHev b 5, 
rHev b 9, rHev b10, rHev b 11), and >99% (rHev b 8). Serum 
samples that proved positive for the H brasiliensis profi lin rHev 
b 8 were additionally screened for sIgE against rBet v 2, the 
recombinant profi lin of white birch (Betula verrucosa) (Biomay, 
Vienna, Austria) at a purity of >98%.
Microarray immunoassays were performed according to 
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the manufacturer’s recommendations as recently published by 
Deinhofer et al [13]. Briefl y, each microarray reaction site was 
incubated with 20 µL of undiluted patient serum for 180 minutes 
in order to capture allergen-specifi c serum IgE antibodies using 
their corresponding allergen molecules. In a second step, the 
microarray slides were washed twice with a conventional Tris-
buffered saline/Tween (TBS-T) buffer solution for 5 minutes, 
rinsed with deionized water, and dried under a nitrogen fl ow. 
Microarray-bound IgE was then marked with a secondary 
fl uorescence-tagged antihuman IgE antibody for 60 minutes 
at room temperature. After a second washing procedure with 
TBS-T, the corresponding fl uorescence signals were scanned 
at a 10-µm resolution using a conventional biochip reader 
(Scan Array Express, Perkin Elmer Life Sciences, Boston, 
Massachusetts, USA). Based on calibration sera of known 
specifi c IgE content, raw data of the corresponding digitized 
microarray images were analyzed with the QuantArray 3.1 
software (Perkin Elmer Life Sciences, Boston, Massachusetts, 
USA) by transforming image information into numerical data 
quantifi ed as dimensionless fl uorescence intensity (FI) values. 
 
Fluorescence Enzyme Immunoassays
Determinations of allergen-specifi c IgE (sIgE) and serum 
total IgE (tIgE) levels were performed with a widely used, 
commercially available FEIA, as proposed by the manufacturer 
(UniCAP, Phadia, Uppsala, Sweden). We assessed sIgE titers 
against latex allergen extract (manufacturer’s code, k72) and 
the recombinant latex allergen components Hev b 1 (k215), 
Hev b 3 (k217), Hev b 5 (k218), Hev b 6.02 (k220), Hev b 8 
(k221), Hev b 9 (k222), Hev b 10 (k223), and Hev b 11 (k224) 
(Phadia). Total and specifi c IgE levels were quantifi ed in protein 
units designated as kU
A
/L according to the product manual. 
Statistics
The obtained data were expressed as mean (SD, range), 
unless otherwise indicated. The serum IgE levels were used 
as response variables during linear regression analysis. The 
Table 1. Demographic and Clinical Characteristics of Recruited Patients and Healthy Controls (n=102)
 Patients Controls
 (n=52) (n=50)
  Age, mean (SD [range]), y 48 (9 [23-68]) 52 (13 [20-73])  
Gender, No. (%) 
  Male 27 (51) 23 (46)
  Female 25 (49) 27 (54)
Severity of reaction, No. (%)  
  I: Contact urticaria 16 (31) 0
  II: Generalized urticaria with(out) angioedema 6 (11) 0
  III: Asthma with(out) rhinoconjunctivitis 28 (54) 0
  IV: Anaphylactic shock 2 (4) 0
  sIgE latexa [kU
A
/L], mean (SD [range]) 15.6 (24, [0.35-100]) 0
Abbreviation: Ig, immunoglobulin.
asIgE latex: allergen-specifi c IgE antibodies against latex extract (k82) as determined by fl uorescence enzyme immunoassay. 
association between microarray and FEIA data was assessed 
using the Pearson correlation coeffi cient. Two-tailed unpaired 
t tests were performed for group comparisons and results were 
considered signifi cant at P<.05. 
Receiver operating characteristic (ROC) curve analysis was 
performed to study the effect of varying sIgE thresholds on the 
test performance of microarray-based and FEIA-based IgE 
detection. The sensitivity, specifi city, positive predictive values 
(PPV), and negative predictive values (NPV) of both test systems 
were calculated using the sIgE cutoff leading to the highest 
accuracy, that is, the maximum value for the sum of sensitivity 
and specifi city. The corresponding 95% confi dence intervals (CI) 
of these diagnostic measures were also calculated. 
All statistical analyses were performed using the S Plus 
6.1 statistical software package (Insightful Corp., Seattle, 
Washington, USA). SigmaPlot 2004 Version 9.01 (Systat 
Software, Erkrath, Germany) was used to graph scatter plots 
and box and whisker plots.
 
Results
The study population comprised 52 latex-allergic 
adults (27 male, 25 female) with a mean (SD [range]) 
age of 48 years (9 [23-68 years]). None of these patients 
suffered from spina bifi da or had undergone multiple surgical 
procedures. Twenty-two (42%) displayed only cutaneous 
symptoms (contact urticaria, generalized urticaria with[out] 
angioedema), while 28 patients (54%) reported respiratory and 
or mucosal reactions (asthma with[out] rhinoconjunctivitis). 
Only 2 cases (4%) of severe anaphylactic shock were identifi ed. 
The control group consisted of 50 insect venom–allergic 
adults (23 male, 27 female) with a mean age of 52 years 
(13 [20-73] years) who had never experienced NRL-associated 
symptoms. Conventional FEIA analysis detected sIgE against 
the NRL extract in 51 patients (98%) at a mean level of 
15.6 kU
A
/L (24.0 [0.35-100 kUA/L]), whereas none of the 
controls revealed extract-specifi c sIgE antibodies (Table 1). 
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Microarray-based assessment of sIgE recognition patterns 
in all 52 patients detected a mean of 2 sensitizations (range, 0-6 
sensitizations) per individual. The NRL proteins rHev b 6.02 
(n=36, 69%), rHev b 5 (n=23, 44%), and rHev b 11 (n=17, 33%) 
elicited the highest rates of positive results, whereas sIgE against 
microarrayed rHev b 9 and rHev b 10 could not be detected at 
all. IgE against the latex profi lin Hev b 8 was detected in 16 
patients (31%), of whom 6 (12%) were also sensitized to the 
birch pollen profi lin Bet v 2. 
At a mean of 1.8 sensitizations (range, 0-7 sensitizations) 
per individual, FEIA analysis yielded similar results with regard 
to the high prevalence of sIgE antibodies against rHev b 6.02 
(n=27, 52%), rHev b 5 (n=26, 50%), and rHev b 11 (n=15, 29%), 
while lower results were observed for rHev b 8 (Table 2). The 
association between FEIA and microarray data is illustrated 
in Figure 1, the respective Pearson correlation coeffi cient was 
calculated at r=0.63 (95% CI, 0.57-0.68). Single correlations of 
FEIA and microarray results obtained with the corresponding 
allergen components are indicated in Table 2. In the control 
group, only 1 patient (2%) revealed sIgE in both assays, and 
this was directed against Hev b 11.
ROC curve analysis yielded an optimal diagnostic threshold 
of >0 kU
A
/L and an FI value >0 for FEIA and microarray testing, 
respectively. At this threshold, sensitivity rates determined with 
the sum of all single-component data were not signifi cantly 
Table 2. Specifi c Immunoglobulin E Recognition Patterns to Recombinant Hevea brasiliensis (rHev b) Allergen Components of All Included Patients 
Suffering From Immediate Type Natural Rubber Latex Allergy (n=52) 
                                           FEIA                                                 Microarray    FEIA vs Microarray
 
Allergen No. (%) Mean (SD [range]) sIgE, No. (%) Mean (SD [range]) sIgE, 
  Pearson Correlation
 
Component  kU
A
/L  kU
A
/L
 Coeffi cient, r
      (95% CI)
 
   rHev b 1   8 (15) 0.3 (0.9 [0.39-5.19]) 12 (23) 974.9     0.82 (0.7-0.89)a
     (3364.9 [1218-22 401]) 
 rHev b 3 4 (8) 0.1 (0.5 [0.5-2.86]) 1 (2) 8704 0.64 (0.44-0.78)a
 rHev b 5 26 (50) 6.1 (14.1 [0.55-80.5]) 23 (44) 28 259.9 0.56 (0.33-0.72)a
     (57 028.3 [1226-256 482])
 rHev b 6.02 27 (52) 5.4 (27.6 [0.48-67.9]) 36 (69) 54 260.3 0.59 (0.34-0.74)a
     (84 668 [1329-275 360])
 rHev b 8 8 (15) 0.3 (1 [0.4-5.24]) 16 (31) 3124.6  0.35 (0.08-0.57)b
     (9906.7 [1077-45 590])
 rHev b 9 5 (10) 0.2 (0.7 [0.43-4.02]) 0 – –
 rHev b 10 1 (2) 4.02 0 – –
 rHev b 11  15 (29) 0.1 (0.6 [0.36-36.5]) 17 (33) 8163.1  0.98 (0.97-0.99)a
     (32 602.2 [1058-225 055])
Abbreviations: CI, confi dence interval; FEIA, fl uorescence enzyme immunoassay; sIgE, specifi c immunoglobulin E.
aP<.0001 
bP<.05
different for the respective recombinant test system (FEIA, 87% 
[95% CI, 74%-94%] vs microarray, 81% [95% CI, 67%-90%], 
whereas the sensitivity level of extract-based FEIA analysis 
was markedly higher (98%; 95% CI, 88%-100%) (Table 3). 
With regard to single components, the highest sensitivity was 
reached with rHev b 6.02 (71% [95% CI, 57%-82%] vs 69% 
[95% CI, 55%-81%]). As positive FEIA and microarray results 
were virtually absent in the control group, specifi city was very 
high (>98%) for both recombinant test systems and the extract-
based FEIA system.
Group comparison of nonsensitized or monosensitized 
patients with polysensitized patients revealed that the number 
of recognized allergen components was signifi cantly correlated 
with the concentration of sIgE against NRL extract as determined 
by Kruskal-Wallis-testing (Figure 2A, B). In contrast, the 
number of sensitizations or the extract-specifi c IgE serum 
levels were not signifi cantly different (P>.05) in patients with a 
history of low-grade cutaneous reactions (grade I, II) compared 
to patients who had suffered from more severe respiratory 
or cardiocirculatory symptoms (grade III, IV). Similarly, no 
signifi cant group differences were observed for component-
specifi c IgE serum levels with the exception of the NRL profi lin 
rHev b 8 and the birch pollen profi lin Bet v 2, which yielded 
signifi cantly more positive results in patients with cutaneous 
reactions only (Table 4).
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Figure 1. Correlation of all specifi c IgE serum levels obtained with FEIA and microarray analysis in 52 patients with natural rubber latex allergy. rp: Pearson 
correlation coeffi cient (95% confi dence interval). 
Table 3. Test Performance of FEIA and Microarray-Based Detection of Component-Specifi c Immunoglobulin E Antibodies in Patients With Immediate-Type 
Natural Rubber Latex Allergy
  FEIA Microarray
 
Allergen
 
Sensitivity,%
 
Specifi city, %
 Positive Negative 
Sensitivity, %
 
Specifi city, %
 Positive Negative
  
(95% CI)
 
(95% CI)
 Predictive Predictive 
(95% CI)
 
(95% CI)
 Predictive Predictive
    Value, % Value, %   Value, % Value, %
    (95% CI) (95% CI)   (95% CI) (95% CI)
 rHev b 1 15 (7-29) 100 (91-100) 100 (60-100) 53 (43-63) 23 (13-37) 100 (91-100) 100 (70-100) 56 (45-66)
 rHev b 3 8 (2-19) 100 (90-100) 100 (40-100) 51 (41-61) 2 (0.1-12) 100 (91-100) 100 (5-100) 50 (39-60)
 rHev b 5 50 (36-64) 100 (91-100) 100 (84-100) 66 (54-76) 44 (31-59) 100 (91-100) 100 (82-100) 63 (52-74)
 rHev b 6.02 71 (57-82) 100 (91-100) 100 (88-100) 77 (65-86) 69 (55-81) 100 (91-100) 100 (88-100) 76 (63-85)
 rHev b 8 15 (7-29) 100 (91-100) 100 (60-100) 53 (43-63) 31 (19-45) 100 (91-100) 100 (76-100) 58 (47-68)
 rHev b 9 10 (4-22) 100 (91-100) 100 (46-100) 52 (41-62) – – – –
 rHev b 10 2 (0.1-12) 100 (91-100) 100 (5-100) 50 (39-60) – – – –
 rHev b 11 29 (18-43) 98 (88-100) 94 (68-100) 57 (46-67) 33 (21-47) 98 (88-100) 94 (71-100) 58 (47-69)
 Combinationa 87 (74-94) 98 (88-100) 98 (87-100) 87 (75-94) 81 (67-90) 98 (88-100) 98 (86-100) 83 (71-91)
 Latex extract 98 (88-100) 100 (91-100) 100 (91-100) 98 (88-100) ND  ND ND ND
Abreviations: CI, confi dence interval; FEIA, fl uorescence enzyme immunoassay; ND, not done.
aSum of all test results obtained by single-component analysis.
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Table 4. Component-Resolved Specifi c Immunoglobulin E Recognition Patterns Detected by FEIA and Microarray Analysis in Natural Rubber Latex–Allergic 
Patients With a History of Cutaneous Reactions (Grade I, II) or Extracutaneous Reactions (Grade III, IV)  
                                    FEIA [kU
A
/L]a                                                  Microarray [FI]a
 
 
Allergen
 Cutaneous Extracutaneous 
P
 Cutaneous Extracutaneous 
P Valueb Component
 Symptoms Symptoms 
Valueb
 Symptoms Symptoms 
  (Severity (Severity  (Severity (Severity
  Grade I + II) Grade III + IV)  Grade I + II) Grade III + IV)  
 rHev b 1 0.3             0.3  .90 415  1383.8 .31
  (0.7 [0.48-2.73]) (1.0 [0.39-5.19])  (913.8 [1256-3921])  (314.6 [1218-22 401])  
 rHev b 3 0.2 (0.6 [0.5-2.86]) 2.52  .52 – 8704 .40
 rHev b 5 5.6  6.5 .82 13 081.7 39390.5 .10
  (16.7 [0.55-80.5]) (11.8 [0.7-46.2])  (31 252 [8121-104 596])  (68030.3 [1226-256482]) 
 rHev b 6.02 5.2  5.4 .96 37 039.9 66888.5  .21  
  (8.5 [0.48-26.9]) (15.4 [0.57-67.9])  (59 880.7 [1690-246 826])   (97052.7 [1329-275360])
 rHev b 8 0.4  0.3  .64 6570.6 597.5 .03
  (1.1 [0.41-4.84]) (1.0 [0.4-5.24])  (14 477.8 [1077-45 590]) (1144 [1653-3630])
 rHev b 9 0.2 (0.7 [0.67-3.48]) 0.1 (0.7 [0.43-4.02]) .69 – – –
 rHev b 10 – 4.02 .40 – – –
 rHev b 11  0.3 (0.7 [0.36-2.4]) 1.8 (6.7 [0.5-36.5]) .31 1511.3  13041 .22
     (3511.5 [1384-15 607])   (42 156.4 [2406-225 055]) 
 rBet v 2  ND ND ND 2821.5  194.2 .02
     (5801.7 [1077-22 459]) (501.2 [1198-1792]) .02  
Abbreviations: FEIA, fl uorescence enzyme immunoassay; FI, fl uorescence intensity; ND, not done.
aFEIA and microarray results are expressed as mean (SD [range]).
bTwo-tailed unpaired t test performed for group comparisons (P<.5)
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Figure 2. Group comparison of NRL extract-specifi c Immunoglobulin E serum levels in patients with no or 1 sensitization, 2 to 3 sensitizations and >4 
sensitizations as determined by microarray (A) and FEIA (B) analysis with 8 recombinant NRL allergen components.
 Discussion
CRD has been reported to be clinically useful in patients with 
immediate-type allergic reactions to a variety of food allergens 
and aeroallergens including recombinant H brasiliensis proteins 
[4,14-17]. Furthermore, proteomic microarrays of recombinant 
and natural allergen components have been described as 
potentially good diagnostic tools in the context of atopic 
diseases such as food allergy or allergic rhinoconjunctivitis 
[8-10,18,19]. However, it is not clear whether microarrays of 
single recombinant H brasiliensis proteins represent a viable 
mode of sIgE determination in humans with NRL allergy. 
Therefore, we analyzed serum samples from 102 adults to 
evaluate the performance of an allergen microarray containing 
8 recombinant H brasiliensis allergen components.
The microarray identifi ed rHev b 5 and rHev b 6.02 as the 
most relevant allergen components eliciting positive sIgE results 
in 44% and 69% of patients, respectively. This is consistent with 
previous reports describing sensitization rates of up to 70% for 
Hev b 5 and 40%-80% for Hev b 6.02 in both adult patients 
and children who had undergone multiple surgical procedures 
[4,5,20]. Moreover, sIgE antibodies against rHev b 11 could 
only be detected in patients who were also sensitized to rHev b 
6.02, probably because of an amino acid sequence homology of 
nearly 60% between rHev b 6.02 and the chitin-binding domain 
of rHev b 11 [21]. 
In contrast, microarrayed rHev b 1 and rHev b 3 elicited sIgE 
responses in only a minority of our study population (<25%). 
This supports the results of earlier publications that defi ned 
these components as specifi c biomarkers of NRL sensitization 
in children suffering from spina bifi da, but not in NRL-allergic 
adults [2,4,22]. The lack of detectable sIgE against rHev b 9 
and rHev b 10 in our population is consistent with previous 
enzyme-linked immunosorbent assay–based and FEIA-based 
studies identifying these NRL components as basically irrelevant 
in the clinical diagnosis of NRL allergy [4,5,23]. 
Intriguingly, FEIA and microarray results revealed good 
levels of correlation with most of the components analyzed. 
These fi ndings are consistent with data recently published by 
Wöhrl et al [10], who assessed the clinical utility of a similar 
protein microarray containing inhalant allergen components. 
By matching combinations of microarrayed recombinant birch 
pollen and grass pollen components with corresponding FEIA 
allergens, the authors demonstrated that assay performance did 
not differ fundamentally between both diagnostic methods. 
However, the rate of sensitization against microarrayed 
NRL profi lin rHev b 8 (31%) was clearly high compared to the 
FEIA results obtained in our population (15%) and previous 
studies of American (16%) and German (14%) health care 
workers [4]. This discrepancy might be attributable to a higher 
analytical sensitivity of the allergen microarray as compared 
to the FEIA method, which has already been demonstrated in 
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standardized dilution assays, particularly for the birch pollen 
profi lin rBet v 2 [24]. Interestingly, 38% of rHev b 8–positive 
sera also recognized rBet v 2, thus implying sensitization to 
cross-reactive plant panallergens [25,26]. Still, 2 of these patients 
were monosensitized to microarrayed rHev b 8 and presented 
with a clear-cut history of contact urticaria immediately after 
NRL exposure. This suggests a possible role of rHev b 8 as a 
clinically relevant NRL allergen, albeit in a small number of 
affected individuals. However, this could not be investigated 
more exhaustively, since further profi lins from other plant 
allergen sources such as timothy grass (Phl p 12), tomato 
(Lyc e 1), or melon (Cuc m 2) were not implemented on the 
microarray used in the present study.
Of note, the panel of allergen components investigated in our 
study can be regarded as a comprehensive repertoire of clinically 
relevant NRL proteins, since the number of sensitizations to 
single microarray components was signifi cantly associated 
with the NRL extract–specifi c IgE level (Figure 2A). This is 
also highlighted by the high rates of sensitivity obtained with 
combined CRD data in both FEIA (87%) and microarray (81%) 
assays. Nevertheless, component-resolved sIgE detection did 
not reach the diagnostic sensitivity of extract-based FEIA 
analysis (98%), irrespective of the component-based test 
method used. This might be due to the fact that linear epitope 
sequences of recombinant proteins that have not undergone 
complete posttranslational modifi cation potentially interfere 
with the recombinant molecule’s IgE-binding capacity [27]. In 
addition, 2 further NRL components (Hev b 2, Hev b 13) were 
not included in the allergen microarray, because they were not 
available in recombinant form at the time of this investigation. 
However, a prior allergenicity study in populations from 3 
distinct geographical areas revealed maximum sensitization 
rates of 15% for purifi ed natural glycosylated Hev b 2 (nHev b 2), 
while nHev b 13 yielded markedly higher sensitization rates of 
up to 30% [28]. Thus, we cannot rule out the possibility that 
the addition of these 2 components would have signifi cantly 
enhanced the microarray’s diagnostic sensitivity. 
It is also noteworthy that the very high degrees of specifi city 
observed for single allergen components and combined CRD 
data in our study are consistent with the results of another 
research group who report specifi cities of 100% using either 
rHev b 6 or a combination of all 13 NRL components [5]. 
Nevertheless, the specifi city data for our patients should be 
interpreted with caution, since the pretest probability could 
have been directly infl uenced by a study population selection 
bias in favor of seronegative controls. This might hamper the 
transferability of our specifi city data to other, nonselected patient 
populations. 
Another crucial area of allergic disease management is the 
capacity to predict whether the affected individual will develop 
severe reactions after exposure to the culprit allergen. In this 
context, CRD has recently identifi ed characteristic sensitization 
patterns that were closely related to the clinical reaction level 
of patients with food allergy [29,30]. On the contrary, sIgE 
profi les associated with a more severe course of NRL allergy 
have not been described to date and could not be demonstrated 
in our patients either. While signifi cantly higher levels of 
rHev b 8–specifi c IgE in patients with mild to moderate clinical 
reactions could be traced back to rBet v 2–associated profi lin 
cross-sensitization, sIgE to the other NRL components was not 
differentially expressed within the investigated patient groups. 
Therefore, NRL-specifi c IgE recognition patterns cannot be 
regarded as reliable biomarkers of severity of reaction in patients 
with latex allergy. 
The present study demonstrates that detection of sIgE 
antibodies against multiple microarrayed allergen components 
can be performed with minimal volumes of patient serum 
that have been shown to be easily obtained by capillary blood 
sampling [31]. Therefore, allergen microarrays might serve 
as minimally invasive tools for NRL-specifi c IgE detection, 
thus avoiding peripheral venipuncture, which is somewhat 
problematic in the case of infants and small children. Perhaps 
even more importantly, the investigated microarray represents a 
diagnostic platform that can be loaded with virtually all allergen 
components of relevance in the context of NRL allergy. This 
would not only drastically empower future epidemiological 
studies, but also clearly enhance the clinical management of 
NRL-allergic patients with symptomatic cross-reactivity 
to plant foods. For instance, natural or recombinant 
marker allergens for the latex-fruit syndrome such as Hev b 
6–homologous class-I-chitinases from chestnut (Cas s 5) and 
banana (Mus a 1), the Hev b 7–homologous patatin-like protein 
from potato (Sol t 1), or the Hev b 2–homologous ß-glucanase 
from olive pollen (Ole e 9) could be implemented using the 
microarray for simultaneous sIgE profi ling [32-35]. Finally, 
trials of NRL-specifi c immunotherapy could be improved by 
the establishment of comprehensive pretreatment sensitization 
patterns that have previously been shown to be relevant, as in 
birch pollen–specifi c immunotherapy [36,37].
In conclusion, allergen microarrays are a novel tool to 
diagnose NRL-specifi c sensitization. They show performance 
characteristics comparable to the current CRD-based sIgE 
detection method and may be particularly indicated in young 
children from whom only small blood volumes are obtainable. 
Additionally, they could signifi cantly broaden our knowledge 
of sensitization patterns in different geographical areas and in 
patient groups with varying NRL allergy risk profi les. Further 
large-scale evaluation studies in unselected patient populations 
and in high-risk groups such as children with spina bifi da are 
warranted before the allergen microarray can be introduced into 
the routine management of patients with NRL allergy.
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